1 Market Overview

• 1.1 Product Overview and Scope of Cannabis-based Medicines
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Cannabis-based Medicines by Type
  • 1.3.1 Overview: Global Cannabis-based Medicines Market Size by Type: 2019 Versus 2023 Versus 2030
  • 1.3.2 Global Cannabis-based Medicines Consumption Value Market Share by Type in 2023
  • 1.3.3 CBD (Cannabidiol) Based
  • 1.3.4 THC (Tetrahydrocannabinol) Based
  • 1.3.5 Others
• 1.4 Global Cannabis-based Medicines Market by Application
  • 1.4.1 Overview: Global Cannabis-based Medicines Market Size by Application: 2019 Versus 2023 Versus 2030
  • 1.4.2 Oral Solution
  • 1.4.3 Tablets
  • 1.4.4 Patches
  • 1.4.5 Others
• 1.5 Global Cannabis-based Medicines Market Size & Forecast
• 1.6 Global Cannabis-based Medicines Market Size and Forecast by Region
  • 1.6.1 Global Cannabis-based Medicines Market Size by Region: 2019 VS 2023 VS 2030
  • 1.6.2 Global Cannabis-based Medicines Market Size by Region, (2019-2030)
  • 1.6.3 North America Cannabis-based Medicines Market Size and Prospect (2019-2030)
  • 1.6.4 Europe Cannabis-based Medicines Market Size and Prospect (2019-2030)
  • 1.6.5 Asia-Pacific Cannabis-based Medicines Market Size and Prospect (2019-2030)
  • 1.6.6 South America Cannabis-based Medicines Market Size and Prospect (2019-2030)
  • 1.6.7 Middle East and Africa Cannabis-based Medicines Market Size and Prospect (2019-2030)

2 Company Profiles

• 2.1 GW Pharmaceuticals plc
  • 2.1.1 GW Pharmaceuticals plc Details
  • 2.1.2 GW Pharmaceuticals plc Major Business
  • 2.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Product and Solutions
  • 2.1.4 GW Pharmaceuticals plc Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019-2024)
  • 2.1.5 GW Pharmaceuticals plc Recent Developments and Future Plans
• 2.2 INSYS Therapeutics
  • 2.2.1 INSYS Therapeutics Details
  • 2.2.2 INSYS Therapeutics Major Business
  • 2.2.3 INSYS Therapeutics Cannabis-based Medicines Product and Solutions
  • 2.2.4 INSYS Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019-2024)
  • 2.2.5 INSYS Therapeutics Recent Developments and Future Plans
• 2.3 Aequus Pharmaceuticals
  • 2.3.1 Aequus Pharmaceuticals Details
  • 2.3.2 Aequus Pharmaceuticals Major Business
  • 2.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Product and Solutions
  • 2.3.4 Aequus Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019-2024)
  • 2.3.5 Aequus Pharmaceuticals Recent Developments and Future Plans
• 2.4 Axim Biotechnologies
  • 2.4.1 Axim Biotechnologies Details
  • 2.4.2 Axim Biotechnologies Major Business
  • 2.4.3 Axim Biotechnologies Cannabis-based Medicines Product and Solutions
  • 2.4.4 Axim Biotechnologies Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019-2024)
  • 2.4.5 Axim Biotechnologies Recent Developments and Future Plans
• 2.5 Revive Therapeutics
  • 2.5.1 Revive Therapeutics Details
  • 2.5.2 Revive Therapeutics Major Business
  • 2.5.3 Revive Therapeutics Cannabis-based Medicines Product and Solutions
  • 2.5.4 Revive Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019-2024)
  • 2.5.5 Revive Therapeutics Recent Developments and Future Plans
• 2.6 MGC Pharmaceuticals
  • 2.6.1 MGC Pharmaceuticals Details
  • 2.6.2 MGC Pharmaceuticals Major Business
  • 2.6.3 MGC Pharmaceuticals Cannabis-based Medicines Product and Solutions
  • 2.6.4 MGC Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019-2024)
  • 2.6.5 MGC Pharmaceuticals Recent Developments and Future Plans
• 2.7 ECHO Pharmaceuticals
  • 2.7.1 ECHO Pharmaceuticals Details
  • 2.7.2 ECHO Pharmaceuticals Major Business
  • 2.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Product and Solutions
  • 2.7.4 ECHO Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019-2024)
  • 2.7.5 ECHO Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Cannabis-based Medicines Revenue and Share by Players (2019-2024)
• 3.2 Market Share Analysis (2023)
  • 3.2.1 Market Share of Cannabis-based Medicines by Company Revenue
  • 3.2.2 Top 3 Cannabis-based Medicines Players Market Share in 2023
  • 3.2.3 Top 6 Cannabis-based Medicines Players Market Share in 2023
• 3.3 Cannabis-based Medicines Market: Overall Company Footprint Analysis
  • 3.3.1 Cannabis-based Medicines Market: Region Footprint
  • 3.3.2 Cannabis-based Medicines Market: Company Product Type Footprint
  • 3.3.3 Cannabis-based Medicines Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Cannabis-based Medicines Consumption Value and Market Share by Type (2019-2024)
• 4.2 Global Cannabis-based Medicines Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

• 5.1 Global Cannabis-based Medicines Consumption Value Market Share by Application (2019-2024)
• 5.2 Global Cannabis-based Medicines Market Forecast by Application (2025-2030)

6 North America

• 6.1 North America Cannabis-based Medicines Consumption Value by Type (2019-2030)
• 6.2 North America Cannabis-based Medicines Consumption Value by Application (2019-2030)
• 6.3 North America Cannabis-based Medicines Market Size by Country
  • 6.3.1 North America Cannabis-based Medicines Consumption Value by Country (2019-2030)
  • 6.3.2 United States Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 6.3.3 Canada Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 6.3.4 Mexico Cannabis-based Medicines Market Size and Forecast (2019-2030)

7 Europe

• 7.1 Europe Cannabis-based Medicines Consumption Value by Type (2019-2030)
• 7.2 Europe Cannabis-based Medicines Consumption Value by Application (2019-2030)
• 7.3 Europe Cannabis-based Medicines Market Size by Country
  • 7.3.1 Europe Cannabis-based Medicines Consumption Value by Country (2019-2030)
  • 7.3.2 Germany Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 7.3.3 France Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 7.3.4 United Kingdom Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 7.3.5 Russia Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 7.3.6 Italy Cannabis-based Medicines Market Size and Forecast (2019-2030)

8 Asia-Pacific

• 8.1 Asia-Pacific Cannabis-based Medicines Consumption Value by Type (2019-2030)
• 8.2 Asia-Pacific Cannabis-based Medicines Consumption Value by Application (2019-2030)
• 8.3 Asia-Pacific Cannabis-based Medicines Market Size by Region
  • 8.3.1 Asia-Pacific Cannabis-based Medicines Consumption Value by Region (2019-2030)
  • 8.3.2 China Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 8.3.3 Japan Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 8.3.4 South Korea Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 8.3.5 India Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 8.3.6 Southeast Asia Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 8.3.7 Australia Cannabis-based Medicines Market Size and Forecast (2019-2030)

9 South America

• 9.1 South America Cannabis-based Medicines Consumption Value by Type (2019-2030)
• 9.2 South America Cannabis-based Medicines Consumption Value by Application (2019-2030)
• 9.3 South America Cannabis-based Medicines Market Size by Country
  • 9.3.1 South America Cannabis-based Medicines Consumption Value by Country (2019-2030)
  • 9.3.2 Brazil Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 9.3.3 Argentina Cannabis-based Medicines Market Size and Forecast (2019-2030)

10 Middle East & Africa

• 10.1 Middle East & Africa Cannabis-based Medicines Consumption Value by Type (2019-2030)
• 10.2 Middle East & Africa Cannabis-based Medicines Consumption Value by Application (2019-2030)
• 10.3 Middle East & Africa Cannabis-based Medicines Market Size by Country
  • 10.3.1 Middle East & Africa Cannabis-based Medicines Consumption Value by Country (2019-2030)
  • 10.3.2 Turkey Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 10.3.3 Saudi Arabia Cannabis-based Medicines Market Size and Forecast (2019-2030)
  • 10.3.4 UAE Cannabis-based Medicines Market Size and Forecast (2019-2030)

11 Market Dynamics

• 11.1 Cannabis-based Medicines Market Drivers
• 11.2 Cannabis-based Medicines Market Restraints
• 11.3 Cannabis-based Medicines Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Cannabis-based Medicines Industry Chain
• 12.2 Cannabis-based Medicines Upstream Analysis
• 12.3 Cannabis-based Medicines Midstream Analysis
• 12.4 Cannabis-based Medicines Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Cannabis-based Medicines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cannabis-based Medicines industry chain, the market status of Oral Solution (CBD (Cannabidiol) Based, THC (Tetrahydrocannabinol) Based), Tablets (CBD (Cannabidiol) Based, THC (Tetrahydrocannabinol) Based), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cannabis-based Medicines.
Regionally, the report analyzes the Cannabis-based Medicines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cannabis-based Medicines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cannabis-based Medicines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cannabis-based Medicines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CBD (Cannabidiol) Based, THC (Tetrahydrocannabinol) Based).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cannabis-based Medicines market.
Regional Analysis: The report involves examining the Cannabis-based Medicines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cannabis-based Medicines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cannabis-based Medicines:
Company Analysis: Report covers individual Cannabis-based Medicines players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cannabis-based Medicines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oral Solution, Tablets).
Technology Analysis: Report covers specific technologies relevant to Cannabis-based Medicines. It assesses the current state, advancements, and potential future developments in Cannabis-based Medicines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cannabis-based Medicines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cannabis-based Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Market segment by Application
Oral Solution
Tablets
Patches
Others
Market segment by players, this report covers
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cannabis-based Medicines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cannabis-based Medicines, with revenue, gross margin and global market share of Cannabis-based Medicines from 2019 to 2024.
Chapter 3, the Cannabis-based Medicines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cannabis-based Medicines market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cannabis-based Medicines.
Chapter 13, to describe Cannabis-based Medicines research findings and conclusion.